Hot Stock UBQU Could Soar More Than 500%…

Ubiquitech Software Corp. (OTC: UBQU)

There is a new and dynamic sector within the Healthcare industry that is changing the game. Its medical benefits are proving to be astronomical and we may have potentially found a company that is poised to be at the forefront of this explosive new industry; a cutting-edge company that combines state-of-the-art technology with a reputable range of diverse medical products.

But first, let’s take a quick look at this sector as a whole:

The US Cannabis market size alone is forecasted to represent approximately $44 billion dollars, and according to a recent Washington Post article, it speculates that there’s up to $120 Billion unaccounted for in what some refer to as “the black market.“ Add in the nutritional supplement market of nearly $37 billion dollars and you have approximately a $200 billion dollar market opportunity.

Now back to this powerful play…

This is one of those rare stock market opportunities that is cashing in on this booming new industry. Through our exhaustive research, we have uncovered a true gem of a company, one with a combination of cheap valuation, catalysts, and explosive growth trends within this emerging sector.

This company has a valuable, growing customer base that all investors will soon want to own a part of. The stock price could TRIPLE or even QUADRUPLE in the short space of 3 months.

This company’s products are at the forefront of the market, merging the highest quality ingredients in the US with a savvy and successful marketing strategy. We decided to feature this stock only because we are 100% convinced of its enormous upside potential to deliver outsized gains to your portfolio – possibly up to 10 times your investment in the longer-term.

All the stars are lining up to make UbiquiTECH Software Corp. (OTC: UBQU) and its subsidiary company HempLife Today, a game-changer in the industry and a profit-making machine for astute investors.

But, before delving further into the explosive potential of UBQU, let’s look at what stocks in this sector have been doing in the last 6 months:


Cannabis Stocks Have Delivered MASSIVE gains.

Cannabis stocks have literally been on fire in the last 6 months, on the back of the legalization of marijuana in Massachusetts, Maine, California, and Nevada. This is in addition to the legalization of medical marijuana in North Dakota, Arkansas, and Florida.

UBQU is perfectly positioned to profit from the boom in CBD oil consumption. And, CBD Oil is an exploding market.

UBQU is already operating through the website, offering a range of brands including the flagship CannazALL™, a high-purity Cannabidiol (CBD) based oil.

Scientific research has shown CBD to be incredibly powerful and health-enhancing, with significant analgesic, anti-cancer, anti-inflammatory, and anti-anxiety properties. All UBQU products are free from GMOs and sourced from the USA’s best growers.

The company’s other products include CBD Tinctures, Oils, GelCaps, CBD Powder, Skin Salve, Wax Crumble, and e-liquid, covering the entire gamut of niches from nutritional use to pharmaceutical use.

Sales & Earnings – Rocketing Upwards

UBQU continues to post excellent sales and earnings numbers. Revenues for 2016 grew to $3.49 MLN, its highest on record. The company anticipates that revenues for the year ending November 30,  2017 will increase over 55% to approximately $5,450,000. Earnings rocketed to $0.33 MLN in 2016 up from $0.04 MLN in 2015, a staggering increase of 840%. These are exceptionally good numbers for a company that is just getting started.

According to CEO Jim Ballas:

“The company was able to reduce its debt during the quarter with a portion of that paid through cash flow from operations and the company successfully added approximately 10,000 new customers during the year…the company finished the year with a comfortable cash flow and with a strong inventory position as well, so we’re very pleased with our growth.”

The company expects to reach 36,000 customers through its HempLifeToday e-commerce platform in 2017, up from 10,000 in 2016, for an increase of 260%.

Q1 2017 sales and earnings again wowed investors with large gains. Revenues for the quarter increased to $1,103,766 from $697,640 (+58.2%) in Q1 2016, while earnings jumped from $34,350 to $113,929 – an impressive +232%.

New Products in 2017 – More Profits in the Pipeline

UBQU announced on March 1st its newest CannazALL™ product called “Honey”, replacing the previous CannazALL™ wax “Crumble” and “Shatter”.

“Honey” not only has higher concentrations of CBD than its predecessors but also lasts longer and contains more beneficial hemp plant ingredients. In other words, a better price-to-value proposition for customers. Company COO Luke Dreyer summed up the potential of the new CannazALL™ at the Q4 2016 Earnings Conference Call:

Company COO Luke Dreyer summed up the potential of the new CannazALL™ at the Q4 2016 Earnings Conference Call:

Our new CannazALL™ Honey is a superior product to our Crumble. It is stronger, delivers more CBD and beneficial plant materials, and is easier to use. Development of this product is also easier for the company giving us a product we can offer for a longer period of time.”

The new CannazALL™ went on sale on March 3rd and the company expects demand to be very strong, which will be fully reflected in Q2 2017 results. UBQU will also introduce new tincture and concentrated oil products during the year, increasing the concentration of CBD to boost their positive health effects.

A name change that could make you a FORTUNE

UBQU’s name involves software and does not immediately relate to Healthcare or CBD. To improve the brand’s positioning and recognition, the company’s board has decided to rename the company in order to better reflect its position as a leader in this emerging healthcare marketplace. This will leverage the brand in the USA and globally, where the company sees great potential growth.

When this happens, a flood of money could be chasing UBQU shares as more investors realize this is a legitimate and rapidly growing health and wellness play.

UBQU – Investment Opportunity of the Year

UBQU is the most exciting play in the sector but it is not the only one. The estimated size of the industry reached $7.1 BLN in 2016, a blistering 25% higher than in 2015. By 2020, legal market sales are expected to surpass $22 BLN, a stunning 200% increase from today.

However, in our opinion, UBQU is the most convincingly undervalued and potentially explosive of all the CBD stock plays. Not only does it provide premium quality products loved by its customers, but its management team has the know-how to deliver expanding sales results over and over.

Brand loyalty is high, with 25% of revenues in 2016 coming from recurring customers. Moreover, the company has launched a new referral program (HLT Referrals) in November 2016 that could increase referral conversion by up to 50% this year.

The sector’s strength is the wind in the sails of UBQU and the catalyst that could make it into an industry giant. In 2015, only 2% of Americans were aware of CBD and its extraordinary health benefits. This number reached 5% in 2016 and in the words of CEO Jim Ballas:

“When this hits critical mass then 15%, 20%, 25% of the American population is aware of CBD products, our sales – the sky is the limit of what our sales can be”.

Furthermore, the public’s attitude towards continued legalization is increasingly positive, with 60% Americans in favor compared to only 32% in 2006. The legislative panorama seems to be moving in the same direction. Delaware, Rhode Island, Kentucky, New Mexico and Vermont expect some form of legalization in 2017.

The Time To Act Is Now

During our research on the burgeoning Natural Cannabis Medication and Supplement division of the Healthcare Industry, UBQU quickly rose to the top with its focus on pain relief and the rapidly growing CBD market segment.

Our recommendation is that you secure your early position in Ubiquitech Software Corp. (OTC: UBQU) right now. Imagine what continued double and triple digit revenue and earnings growth would mean for UBQU. Life-changing gains are possible.

Do your own research on UBQU and we are sure you will also find it a unique opportunity with enormous upside. Do not wait, early investors typically experience the largest gains.

This Market Is Exploding and UBQU Is Poised for Significant Growth.



DISCLAIMER: This financial news and information portal (, and/or our newsletters contain commercial advertisements, and are for general entertainment purposes only. Along with the aggregation of timely financial news, we are engaged in the business of analyzing, marketing and advertising companies for monetary compensation. Unless otherwise stated below, the paying Third Party for our services may own shares and may liquidate them during any and all advertising periods. This disclaimer is to be read and fully understood before using, or joining one of our newsletter lists. We also encourage you to read the SEC INVESTOR ALERT before reading content found on and/or our newsletters. You are reading content found on our financial news and informational portal because you have clicked on an advertisement found on one of many marketing channels we advertise on. is for entertainment purposes only. We are NOT a source of unbiased information. Never invest in any stock featured on our site or newsletters unless you can afford to lose your entire investment. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled on the website/newsletter and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead, strongly urges you to supplement the information obtained from this website/newsletter with a complete and independent investigation of the companies discussed and a consideration of all pertinent risks. Investing in securities, including the securities of the companies profiled or discussed on this website/newsletter, is highly speculative and carries a high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies discussed. The information found on, and/or our newsletters are based on sources, which we believe to be reliable, but are not guaranteed by us as being accurate and do not purport to be a complete statement or summary of the available data. encourages readers and investors to supplement the information found on our site or in our newsletters with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources. makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the featured companies None of the owners of, or any of its directors, officers, employees, contractors, or affiliates is a licensed broker-dealer, account representative, market maker, investment banker, investment advisor, analyst or underwriter in any jurisdiction whatsoever. does not offer such advice or analysis, and further urges you to consult your own independent tax, business, financial and investment advisors before purchasing or selling any securities of the companies discussed on this website/newsletter. Compensation: may be compensated for up to seven-hundred and fifty thousand USD via bank wire by an unaffiliated Third Party for continuous analyzing, marketing and advertising services. does not own any shares of any featured company. The Third Party may own shares and may sell all, any or none of any shares held in any featured company during advertisement periods, which may negatively affect the featured company’s stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the featured company. and its employees, contractors, officers, directors, or affiliates may purchase shares on the open market of any mentioned featured company during advertisement periods and following the dissemination of any newsletters. This is an inherent conflict of interest. The services provided by this website/newsletter and its contents are provided “as is” and makes no representations or warranties of any kind with respect to this website/newsletter, its contents or its services. This website/newsletter has been prepared solely for the purpose of providing information about and the services it offers. This website/newsletter has been compiled in good faith by assumes no liability or responsibility for any errors or omissions in the content of this website/newsletter, any failures, delays, or interruptions in its services or any content contained on this website/newsletter, any losses or damages arising from the use of the content provided on this website/newsletter, or any conduct by users of’s services. reserves the right to add, modify or delete any information at this website/newsletter at any time. This website/newsletter may contain “forward-looking” information within the meaning of the Private Securities Litigation Reform Act of 1995. In accordance with the safe harbor provisions of this Act, statements contained herein that look forward in time that includes everything other than historical information, involve risks and uncertainties that may affect the companies’ actual results. There can be no assurance that such statements will prove to be accurate and there are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made in this report. Further specific financial information, filings, and disclosures as well as general investor information about the profiled companies, advice to investors and other investor resources are available at the Securities and Exchange Commission (“SEC”) website and the Financial Industry Regulatory Authority (“FINRA”) website at undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise. In addition to information about the company discussed, from time to time, this website/newsletter may contain the symbols of companies and/or news feeds or links to websites about companies that are not being discussed by us but are merely illustrative of certain activity in the stock market that we are highlighting (so-called hyperlinks to third party websites or access to third party content). Readers are advised that all links and access to these sites and content solely for informational purposes., its owners, directors, officers, employees, affiliates, and contractors are not responsible for errors and omissions nor does control, endorse, or guarantee any content found in such sites or content. Any opinions expressed are subject to change without notice. It is also possible that the companies discussed on those sites may not have approved certain or any statements within the report. By accessing or viewing this website/newsletter, you agree that, its owners, directors, officers, employees, affiliates and contractors are not responsible for any content, associated links, resources, or services associated with a third-party website. uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. In no event shall, its owners, directors, officers, employees, affiliates and contractors be liable (jointly or severally) for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with this website/newsletter. You agree to hold, its owners, directors, officers, employees, affiliates and contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of the information contained on this website/newsletter (including any loss or damage of any sort associated with your use of third party content). You agree that use of this website/newsletter is at your sole risk. disclaims all warranties of any kind, express or implied. If any applicable authority holds any portion of this section to be unenforceable, then liability will be limited to the fullest possible extent permitted by applicable law. encourages readers to invest carefully, and read investor and issuer information available at the websites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at and filings made by public companies can be viewed at . In addition, FINRA has published information at its website on how to invest carefully at Questions regarding any information contained on this website/newsletter may be sent to To review’s website and its disclaimer, please visit